Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (54)

Advertisement

Free access | 10.1172/JCI109177

Adenosine Triphosphatases of Rat Pancreatic Islets: COMPARISON WITH THOSE OF RAT KIDNEY

Seymour R. Levin, Barry G. Kasson, and June F. Driessen

Medical Service and Diabetes Research Laboratory, Wadsworth Veterans Administration Hospital, Los Angeles, California 90073

Department of Medicine, University of California at Los Angeles, Los Angeles, California 90073

Find articles by Levin, S. in: PubMed | Google Scholar

Medical Service and Diabetes Research Laboratory, Wadsworth Veterans Administration Hospital, Los Angeles, California 90073

Department of Medicine, University of California at Los Angeles, Los Angeles, California 90073

Find articles by Kasson, B. in: PubMed | Google Scholar

Medical Service and Diabetes Research Laboratory, Wadsworth Veterans Administration Hospital, Los Angeles, California 90073

Department of Medicine, University of California at Los Angeles, Los Angeles, California 90073

Find articles by Driessen, J. in: PubMed | Google Scholar

Published September 1, 1978 - More info

Published in Volume 62, Issue 3 on September 1, 1978
J Clin Invest. 1978;62(3):692–701. https://doi.org/10.1172/JCI109177.
© 1978 The American Society for Clinical Investigation
Published September 1, 1978 - Version history
View PDF
Abstract

Electrolyte fluxes are fundamental to normal endocrine pancreatic function. Adenosine triphosphatases (ATPases) are enzyme systems believed to modulate electrolyte movements across membranes in a number of cell types. This study was undertaken to measure cation-dependent ATPases of rat pancreatic islets. In addition, we compared effects of substances which influence endocrine pancreatic function upon ATPases in homogenates of islets and kidney, the latter being a tissue which would not be expected to have a stimulus-secretion response to substances which activate islets.

Both tissues were generally similar with respect to apparent Michaelis constant (ATP) of Na+K+ATPase, Mg++ATPase, and Ca++ATPase. In islets and kidney, Na+K+ATPase specific activity was increased when the Na:K ratio was lowered from 250:1 (175:0.7 mM) to 5:1 (100:20 mM). Inhibition of Na+K+ATPase at either Na:K ratio by ouabain, an activator of secretion, and enhancement of the high-ratio Na+K+ATPase by diphenylhydantoin, an islet secretory inhibitor, were also common to both tissues.

Because both inhibition and enhancement of Na+K+ATPase could be studied at the high Na:K ratio, we examined the effect of regulators of secretion upon the activity of this enzyme. Like ouabain, substances which induce or support islet secretion, glucose 16 mM or 3.3 mM, arginine 14.2 mM (with 3.3 mM glucose), or Ca++ 1 mM, inhibited high-ratio islet Na+K+ATPase. Like diphenylhydantoin, the inhibitors of insulin secretion, diazoxide 0.22 mM, or NH4Cl 16 mM, enhanced this islet ATPase. Neither valine, which is non-secretogenic, nor arginine without glucose, which is a weak secretagogue, had any effect upon islet Na+K+ATPase. We examined the effect of these substances upon other cation-dependent islet ATPases. Ca++ inhibited Mg++ATPase, and glucose inhibited Ca++ATPase. Leucine, 22.9 mM, which induces insulin secretion in the absence of glucose, suppressed islet Ca++ATPase and had no effect upon high-ratio Na+K+ATPase.

In contrast to the observations in the islets, most substances which influence islet function had no effect on kidney ATPases, or effects which were different from those seen in islets. Except for ouabain, none of these substances influenced the three kidney ATPases in a manner similar to that seen with islets.

These findings support the hypothesis that cation-dependent ATPases are involved in specificity of islet response to substances which influence endocrine pancreatic activity.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 692
page 692
icon of scanned page 693
page 693
icon of scanned page 694
page 694
icon of scanned page 695
page 695
icon of scanned page 696
page 696
icon of scanned page 697
page 697
icon of scanned page 698
page 698
icon of scanned page 699
page 699
icon of scanned page 700
page 700
icon of scanned page 701
page 701
Version history
  • Version 1 (September 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (54)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts